Detalhe da pesquisa
1.
Identifying homologous recombination deficiency in breast cancer: genomic instability score distributions differ among breast cancer subtypes.
Breast Cancer Res Treat
; 202(1): 191-201, 2023 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-37589839
2.
Hereditary cancer risk assessment and genetic testing in the community urology practice setting.
Prostate
; 82(7): 850-857, 2022 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-35239202
3.
Cell Cycle Progression Score, but Not Phosphatase and Tensin Homolog Loss, Is an Independent Prognostic Factor for Metastasis in Intermediate- and High-risk Prostate Cancer in Men Treated With and Without Salvage Radiotherapy.
J Urol
; 208(6): 1182-1193, 2022 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-36006048
4.
Cell-cycle risk score more accurately determines the risk for metastases and death in prostatectomy patients compared with clinical features alone.
Prostate
; 81(4): 261-267, 2021 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-33475174
5.
Reply by Authors.
J Urol
; 208(6): 1192-1193, 2022 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-36349916
6.
Using the Cell-Cycle Risk Score to Predict the Benefit of Androgen-Deprivation Therapy Added to Radiation Therapy in Patients With Newly Diagnosed Prostate Cancer.
JCO Precis Oncol
; 8: e2300722, 2024 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-38748970
7.
Validation of the cell cycle progression score to differentiate indolent from aggressive prostate cancer in men diagnosed through transurethral resection of the prostate biopsy.
Cancer Rep (Hoboken)
; 5(8): e1535, 2022 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-34423592
8.
Development and validation of a cell cycle progression signature for decentralized testing of men with prostate cancer.
Biomark Med
; 16(6): 449-459, 2022 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-35321552
9.
The Clinical Cell-Cycle Risk (CCR) Score Is Associated With Metastasis After Radiation Therapy and Provides Guidance on When to Forgo Combined Androgen Deprivation Therapy With Dose-Escalated Radiation.
Int J Radiat Oncol Biol Phys
; 113(1): 66-76, 2022 05 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-34610388
10.
Prognostic capabilities and clinical utility of cell cycle progression testing, prostate imaging reporting and data system, version 2, and clinicopathologic data in management of localized prostate cancer.
Urol Oncol
; 39(6): 366.e19-366.e28, 2021 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-33257218
11.
Personalizing Localized Prostate Cancer: Validation of a Combined Clinical Cell-cycle Risk (CCR) Score Threshold for Prognosticating Benefit From Multimodality Therapy.
Clin Genitourin Cancer
; 19(4): 296-304.e3, 2021 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-33608228
12.
In Regard to Dess.
Int J Radiat Oncol Biol Phys
; 115(1): 261-263, 2023 Jan 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-36526395